Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis.
Onoue K, Uemura S, Takeda Y, Somekawa S, Iwama H, Imagawa K, Nishida T, Morikawa Y, Takemoto Y, Asai O, Soeda T, Okayama S, Ishigami K, Nakatani K, Kawata H, Horii M, Nakajima T, Akai Y, Iwano M, Saito Y.
Onoue K, et al. Among authors: ishigami k.
Circulation. 2009 Dec 15;120(24):2470-7. doi: 10.1161/CIRCULATIONAHA.109.867929.
Circulation. 2009.
PMID: 19948974